Patent 7547794 was granted and assigned to Vertex Pharmaceuticals on June, 2009 by the United States Patent and Trademark Office.
The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.